Clinical trials in Amersfoort – page 4

117 clinical trials in Amersfoort, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Amersfoort at a glance

117

clinical trials

Paediatric trials0
Research sites1

Quick filters

117 trials in Amersfoort

Open in trial search

Dose-Reduced Oxaliplatin and Drug Combination Study for Older Patients with Metastatic Colorectal Cancer

Registered drugNo placebo

The Netherlands

Participants:65+ years
Substances:Capecitabine
Sponsor:Leids Universitair Medisch Centrum (LUMC)

Contact Research Centre

Study on Rosuvastatin and Placebo for Patients with Statin Intolerance and High Cardiovascular Risk

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Atorvastatin Calcium
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Colorectal cancer metastatic+2

Recruiting

Registered drugNo placebo

Study on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Contact Research Centre

Hormone-refractory prostate cancer

Recruiting

InvestigationalNo placebo

Study on the Safety and Effects of Lutetium (177Lu) rhPSMA-10.1 Injection in Men with Advanced Prostate Cancer

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:177Lu-Rhpsma-10.1
Sponsor:Blue Earth Therapeutics Limited

Contact Research Centre

Study on Cobicistat, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Study on Omega-3 Fatty Acids for Reducing Organ Failure and Mortality in Patients with Severe Acute Pancreatitis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Glycerol
Sponsor:Stichting Radboud University Medical Center

Contact Research Centre

Study on Shortened Treatment with Apalutamide and Enzalutamide for Patients with Low-Volume Metastatic Castration-Sensitive Prostate Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Apalutamide
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Study on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cytarabine
Sponsor:Universitaetsklinikum Ulm AöR

Contact Research Centre

Chronic lymphocytic leukaemia+1

Recruiting

InvestigationalNo placebo

Study on Venetoclax and Epcoritamab for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Epcoritamab
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Study of drug combination (capecitabine, fluorouracil, oxaliplatin, calcium folinate) to prevent cancer recurrence in patients with detectable ctDNA after rectal cancer surgery

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Study on Timing of Chemotherapy with Paclitaxel Albumin-Bound and Drug Combination for Patients with Metastatic Pancreatic Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Amsterdam UMC

Contact Research Centre

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Amersfoort

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on advanced cancer treatments, including studies for breast cancer, prostate cancer, and leukemia. Research encompasses targeted therapies and novel drug combinations.

Breast Cancer Treatment Studies
Prostate Cancer Interventions
Hematological Malignancies

Emphasis on personalized treatment approaches and improving patient outcomes through targeted therapies.

02 Cardiovascular Studies

Research initiatives exploring cardiovascular disease management and prevention, including innovative treatments for reducing major cardiovascular events and improving patient outcomes.

Lipid Management Studies
Heart Disease Prevention
Cardiovascular Risk Reduction

Focus on developing new therapeutic approaches for cardiac conditions and preventive strategies.

03 Neurological Disorders

Clinical investigations into dementia and related conditions, studying new approaches to manage behavioral symptoms and improve patient care outcomes.

Dementia Management
Behavioral Interventions
Therapeutic Approaches

Dedicated to understanding and treating complex neurological conditions with innovative therapies.

Back to the Netherlands All countries